Seres Therapeutics, Inc. MCRB Balance Sheet

Seres therapeutics, inc. (MCRB)

Balance Sheet / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Dec'14
Assets
Current assets:
Cash and cash equivalents
54,857	65,126	49,296	102,230	53,600	85,820	55,713	57,960	47,194	36,088	46,025	33,642	41,899	54,539	55,611	59,824	193,228	73,933	69,702	36,338	114,185
Investments
20,237	29,690	34,492	-	-	0	17,177	-	-	113,895	-	-	-	-	-	-	-	-	-	-	-
Investments
-	-	-	-	-	-	-	38,106	75,000	-	125,274	137,570	145,174	138,704	147,768	152,032	110,050	131,149	149,641	55,438	-
Prepaid expenses and other current assets
3,385	3,588	4,073	5,160	7,488	6,845	6,556	5,471	4,260	5,095	5,346	4,839	5,188	5,126	5,055	5,247	3,568	2,528	3,020	2,288	58
Accounts receivable
2,084	1,785	1,717	1,604	6,667	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total current assets
80,563	100,189	89,578	108,994	67,755	92,665	79,446	101,537	126,454	155,078	176,645	176,051	192,261	198,369	208,434	217,103	306,846	207,610	222,363	94,064	114,243
Property and equipment, net
17,836	19,495	21,160	22,945	24,571	26,294	28,083	29,904	31,466	32,931	33,724	34,813	36,089	36,125	34,560	26,985	16,082	7,751	4,543	3,319	1,264
Operating lease assets
10,820	11,356	11,899	12,640	13,202	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Restricted investments
1,400	1,400	1,400	1,400	1,400	1,400	-	-	-	1,400	-	-	-	-	-	-	-	-	-	-	-
Restricted cash
-	-	114	114	114	113	1,513	-	-	113	-	-	-	-	-	-	-	-	-	-	-
Long-term investments
-	-	-	-	-	-	-	-	-	-	-	3,962	15,099	36,752	53,098	60,589	-	-	-	-	-
Restricted cash
-	-	-	-	-	-	-	1,513	1,513	-	1,513	1,513	1,401	1,400	1,422	1,540	1,540	1,539	139	139	139
Deferred offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,684
Deferred offering costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	3,748	-
Deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	11	15
Total assets
110,619	132,440	124,151	146,093	107,042	120,472	109,042	132,954	159,433	189,522	211,882	216,339	244,850	272,646	297,514	306,217	324,468	216,900	227,045	101,281	117,345
Liabilities and Stockholders’ Deficit
Current liabilities:
Accounts payable
5,521	4,859	4,455	4,764	3,918	6,415	6,475	5,158	5,418	7,033	5,380	3,889	5,636	7,587	4,228	4,454	5,763	5,397	2,089	1,688	2,166
Accrued expenses and other current liabilities
9,141	10,884	10,522	10,589	11,789	15,207	-	-	-	12,513	-	-	-	-	-	-	-	-	-	-	-
Operating lease liabilities
4,623	4,456	4,335	4,449	4,407	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue - related party
19,974	20,960	21,135	20,582	18,685	20,419	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Accrued expenses and other current liabilities
-	-	-	-	-	-	14,634	13,651	11,873	-	9,594	9,718	9,550	10,812	15,623	10,865	7,059	5,523	2,757	2,753	1,737
Deferred revenue
4,855	4,834	1,790	2,689	2,770	-	17,901	17,962	-	12,079	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue - related party
-	-	-	-	-	-	-	-	17,859	-	12,058	12,058	12,058	12,058	12,027	12,012	12,000	-	-	-	-
Notes payable; current portion
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,200	1,200
Total current liabilities
44,114	45,993	42,237	43,073	41,569	42,041	39,010	36,771	35,150	31,625	27,032	25,665	27,244	30,457	31,878	27,331	24,822	10,920	4,846	5,641	5,103
Note payable, net of discount
24,754	24,648	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	727	1,304
Operating lease liabilities, net of current portion
14,444	15,676	16,844	17,969	19,066	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Lease incentive obligation, net of current portion
-	-	-	-	-	6,776	7,685	8,119	8,554	8,989	9,424	9,859	10,295	10,730	10,740	9,119	4,527	586	-	-	-
Deferred rent
-	-	-	-	-	2,216	2,229	2,231	2,234	2,233	2,202	2,159	2,117	2,072	1,381	-	-	-	-	-	-
Deferred revenue, net of current portion - related party
84,635	89,111	94,215	99,608	111,959	116,840	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue, net of current portion
3,641	4,834	2,410	2,752	3,637	-	89,554	97,959	-	84,847	-	-	-	-	-	-	-	-	-	-	-
Deferred revenue, net of current portion - related party
-	-	-	-	-	-	-	-	102,333	-	87,712	90,727	93,741	96,756	99,518	102,371	105,290	-	-	-	-
Other long-term liabilities
680	502	664	659	644	644	1,129	1,129	1,129	1,129	-	-	-	-	-	-	-	-	-	-	-
Preferred stock warrant liability
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,582
Total liabilities
172,268	180,764	156,370	164,061	176,875	168,517	139,607	146,209	149,400	128,823	126,370	128,410	133,397	140,015	143,517	138,821	134,639	11,506	4,846	6,368	7,989
Commitments and contingencies (Note 11)
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	0	0	0	0	0
Stockholders’ deficit:
Preferred stock, $0.001 par value; 10,000,000 shares authorized at March 31, 2020 and December 31, 2019; no shares issued and outstanding at March 31, 2020 and December 31, 2019.
-	-	-	-	-	-	0	0	0	-	0	0	0	0	0	0	-	0	-	-	-
Common stock, $0.001 par value; 200,000,000 shares authorized at March 31, 2020 and December 31, 2019; 71,671,067 and 70,143,252 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively
72	70	70	70	41	41	41	40	40	40	40	40	40	40	40	40	39	39	39	31	7
Additional paid-in capital
417,819	411,255	408,575	406,424	343,829	341,284	337,486	332,870	328,446	324,376	320,189	315,748	311,229	306,931	302,939	297,502	291,998	287,937	285,148	143,217	1,104
Accumulated other comprehensive income (loss)
-10	-	7	-	-	-	-9	-29	-106	-146	-99	-176	-151	-149	-67	83	108	30	-10	23	-
Accumulated deficit
-479,530	-459,649	-440,871	-424,462	-413,703	-389,370	-368,083	-346,136	-318,347	-263,571	-234,618	-227,683	-199,665	-174,191	-148,915	-130,229	-102,316	-82,612	-62,978	-48,358	-27,832
Total stockholders’ deficit
-61,649	-48,324	-32,219	-17,968	-69,833	-48,045	-30,565	-13,255	10,033	60,699	85,512	87,929	111,453	132,631	153,997	167,396	189,829	205,394	222,199	94,913	-26,721
Total liabilities and stockholders’ deficit
110,619	132,440	124,151	146,093	107,042	120,472	109,042	132,954	159,433	189,522	211,882	216,339	244,850	272,646	297,514	306,217	324,468	216,900	227,045	101,281	117,345